Genetic Signatures Limited (ASX:GSS)
Australia · Delayed Price · Currency is AUD 0.0870
+0.0060 (7.41%)
Sep 8, 2026, 12:30 PM AEST
Genetic Signatures Market Cap
Genetic Signatures has a market cap or net worth of 18.4 million as of September 4, 2026. Its market cap has decreased by -71.07% in one year.
Market Cap
18.40M
Enterprise Value
-3.39M
Revenue
19.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
ChartMarket Cap Chart
Since March 31, 2015, Genetic Signatures's market cap has decreased from 35.38M to 18.40M, a decrease of -47.99%. That is a compound annual growth rate of -5.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 18.40M | -67.60% |
| Dec 31, 2025 | 56.79M | -60.32% |
| Dec 31, 2024 | 143.10M | 99.47% |
| Dec 29, 2023 | 71.74M | -43.15% |
| Dec 30, 2022 | 126.20M | -50.73% |
| Dec 31, 2021 | 256.15M | -10.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 508.88M |
| Healius | 330.40M |
| Monash IVF Group | 315.60M |
| Cryosite | 61.01M |
| Microba Life Sciences | 39.44M |
| Rhythm Biosciences | 30.79M |
| INOVIQ | 26.04M |
| BCAL Diagnostics | 25.44M |